AlloVir
is a Massachusetts-based biotechnology company that discovers and develops T-cell therapies for the treatment of viral diseases... Read moreAlloVir
is a Massachusetts-based biotechnology company that discovers and develops T-cell therapies for the treatment of viral diseases... Read more
News
Mar 18, 2026
Owler
AlloVir, Inc.: AlloVir's employee count changed from 6 in Dec 2024 to 20 in Dec 2025
Aug 07, 2025
GlobalNewswire
Press Release: AlloVir : ALLOVIR ALERT: Bragar Eagel & Squire, P.C. is Investigating AlloVir, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Jun 05, 2025
Benzinga
AlloVir: Bernstein Liebhard LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of AlloVir, Inc. Securities
Jun 05, 2025
Benzinga
AlloVir: Bernstein Liebhard LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of AlloVir, Inc. Securities
Mar 21, 2025
VisionMonday
AlloVir: Kalaris Therapeutics Announces Closing of Merger With AlloVir
Mar 18, 2025
Benzinga
AlloVir: Kalaris Announces Closing of Merger with AlloVir
Dec 22, 2024
Americanbankingnews
AlloVir: **AlloVir Announces Chief Executive Officer Transition and Appointment of New CEO**
Nov 11, 2024
Pharamceutical Technology
AlloVir: AlloVir and Kalaris enter merger to advance retinal disease therapies
Nov 08, 2024
Benzinga
AlloVir: STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of AlloVir, Inc. - ALVR
Sep 16, 2024
Benzinga
AlloVir: Kuehn Law Encourages Investors of AlloVir, Inc. to Contact Law Firm
AlloVir Competitors
1
2
3
4
5
6
7
8
9
10